TEOSYAL RHA 1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TEOSYAL RHA 1, covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults [NA]